Fig. 1From: Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot studyMean change in CST from baseline (95% C.I.). This graph depicts the change in central subfield thickness from baseline to 36-week visit. The average change from baseline for the treatment group was − 54.0 μm (− 106.7, − 1.4). The average change from baseline for the control group was − 0.1 μm (− 73.1, 72.9)Back to article page